Paper2982011
Neurochemical and functional correlates of naltrexone-induced opiate receptor up-regulation.
Tempel A and 2 others. J Pharmacol Exp Ther, 1985. Cited by 194 papers, by iCite.
Cite this record
ConductScience Library. Neurochemical and functional correlates of naltrexone-induced opiate receptor up-regulation. Papers, record 2982011. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2982011
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Brain Chemistry | Major topic |
| Naloxone | Major topic |
| Naltrexone | Major topic |
| Receptors, Opioid | Major topic |
| Animals | |
| Guanosine Triphosphate | |
| Male | |
| Morphine | |
| Pain | |
| Rats | |
| Rats, Inbred Strains | |
| Time Factors |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| DA 00069 | NIDA NIH HHS | United States | PubMed | PubMed | |
| DA 01843 | NIDA NIH HHS | United States | R01DA001843 | PubMed and NIH | NIH RePORTER |
| HD 07154 | NICHD NIH HHS | United States | PubMed | PubMed |
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT04502251 | LDN and tDCS in Fibromyalgia | Background |
Source ClinicalTrials.gov
Cited by29
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 194 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39067531 | Enhancing translation: A need to leverage complex preclinical models of addictive drugs to accelerate substance use treatment options. | Pharmacol Biochem Behav | 2024 | https://conductscience.org/library/papers/39067531 | PubMed |
| 39000086 | Susceptibility to Pentylenetetrazole-Induced Seizures in Mice with Distinct Activity of the Endogenous Opioid System. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39000086 | PubMed |
| 38539570 | Low-Dose Naltrexone as an Adjuvant in Combined Anticancer Therapy. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38539570 | PubMed |
| 38473865 | The Role of Opioid Receptor Antagonists in Regulation of Blood Pressure and T-Cell Activation in Mice Selected for High Analgesia Induced by Swim Stress. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38473865 | PubMed |
| 38291050 | Sex dependence of opioid-mediated responses to subanesthetic ketamine in rats. | Nat Commun | 2024 | https://conductscience.org/library/papers/38291050 | PubMed |
| 38236555 | The role of bidirectional communication between the adipokines and the endogenous opioid system in an experimental mouse model of colitis-associated colorectal cancer. | Pharmacol Rep | 2024 | https://conductscience.org/library/papers/38236555 | PubMed |
| 37706146 | Low-Dose Naltrexone Use in Postural Orthostatic Tachycardia Syndrome: A Case Series. | Cureus | 2023 | https://conductscience.org/library/papers/37706146 | PubMed |
| 37599869 | Association between body mass index and treatment completion in extended-release naltrexone-treated patients with opioid dependence. | Front Psychiatry | 2023 | https://conductscience.org/library/papers/37599869 | PubMed |
| 37115486 | Treatment of Acute Pain in Patients on Naltrexone: A Narrative Review. | Curr Pain Headache Rep | 2023 | https://conductscience.org/library/papers/37115486 | PubMed |
| 33061915 | Reconsidering the Usefulness of Adding Naloxone to Buprenorphine. | Front Psychiatry | 2020 | https://conductscience.org/library/papers/33061915 | PubMed |
| 32950543 | Pain management in hidradenitis suppurativa and a proposed treatment algorithm. | J Am Acad Dermatol | 2021 | https://conductscience.org/library/papers/32950543 | PubMed |
| 30248938 | Low-Dose Naltrexone (LDN)-Review of Therapeutic Utilization. | Med Sci (Basel) | 2018 | https://conductscience.org/library/papers/30248938 | PubMed |
| 30245561 | Naltrexone Maintenance: Effect on Morphine Sensitivity in Normal Volunteers. | Am J Addict | 1993 | https://conductscience.org/library/papers/30245561 | PubMed |
| 30073490 | Potential Risk Window for Opioid Overdose Related to Treatment with Extended-Release Injectable Naltrexone. | Drug Saf | 2018 | https://conductscience.org/library/papers/30073490 | PubMed |
| 29410949 | Opiate Drugs with Abuse Liability Hijack the Endogenous Opioid System to Disrupt Neuronal and Glial Maturation in the Central Nervous System. | Front Pediatr | 2017 | https://conductscience.org/library/papers/29410949 | PubMed |
| 29146290 | Sustained opioid antagonism modulates striatal sensitivity to baby schema in opioid use disorder. | J Subst Abuse Treat | 2018 | https://conductscience.org/library/papers/29146290 | PubMed |
| 24526250 | The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain. | Clin Rheumatol | 2014 | https://conductscience.org/library/papers/24526250 | PubMed |
| 19273091 | Chaperone-like effects of cell-permeant ligands on opioid receptors. | Front Biosci (Landmark Ed) | 2009 | https://conductscience.org/library/papers/19273091 | PubMed |
| 16960700 | Association of OPRM1 A118G variant with the relative reinforcing value of nicotine. | Psychopharmacology (Berl) | 2006 | https://conductscience.org/library/papers/16960700 | PubMed |
| 16461865 | Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial. | Arch Gen Psychiatry | 2006 | https://conductscience.org/library/papers/16461865 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| OPRM1 | 4988 | PubTator's text mining | https://conductscience.org/library/genes/4988 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2982011
GET https://conductscience.org/api/papers/v1/2982011/cited_by?page=2